Answers are grounded in this paper and cite their sources.
No HLA allele or specificity was significantly different in frequency between a group of 150 cervical cancer patients from north-west England and controls (corrected P values). HLA-DRB1*1501/DQB1*0602 was non-significantly increased, particularly among patients with HPV16-positive tumours. HLA-B7-positive patients had a significantly poorer clinical outcome than HLA-B7-negative patients. A significant component of the genotypic effect is down-regulation of HLA-B7 expression by the tumour cells.
No takes yet. Share an insight, caveat, or question.
Duggan‐Keen et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: